NCT05885360View on ClinicalTrials.gov

Istradefylline Effect Protocol on Parkinson's Disease Tremor

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

February 21, 2025

Conditions
Parkinson DiseaseTremor
Interventions
DRUG

Istradefylline Pill

"Istradefylline targets adenosine A2A receptors in the basal ganglia, by inhibiting the indirect pathway It is an adjunctive treatment to carbidopa-levodopa indicated to improve on time and decrease off time."

Trial Locations (1)

22101

Georgetown University Hospital, McLean

Sponsors

Collaborators (1)

Kyowa Kirin, Inc.
All Listed Sponsors
collaborator

Kyowa Kirin, Inc.

INDUSTRY

lead

Georgetown University

OTHER